Nevertheless, to explore the underlying mechanisms of FDX1 regulating cuproptosis in ccRCC, more experiments on the intracellular copper level, mitochondrial ROS induction, and vital protein alterations should be done as further validation (25, 26). The gene discussed is FDX1; the disease is nonpapillary renal cell carcinoma.